Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors

被引：102

作者：

Ikegashira, Kazutaka

Oka, Takahiro

Hirashima, Shintaro

Noji, Satoru

Yamanaka, Hiroshi

Hara, Yoshinori

Adachi, Tsuyoshi

Tsuruha, Jun-Ichiro

Doi, Satoki

Hase, Yasunori

Noguchi, Toru

Ando, Izuru

Ogura, Naoki

Ikeda, Satoru

Hashimoto, Hiromasa

机构：

[1] Japan Tobacco Inc, Cent Pharmaceut Res Inst, Takatsuki, Osaka 5091125, Japan

[2] Japan Tobacco Inc, Pharmaceut Frontier Res Labs, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2006年 / 49卷 / 24期

关键词：

D O I：

10.1021/jm0610245

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We report a new series of hepatitis C virus NS5B RNA polymerase inhibitors containing a conformationally constrained tetracyclic scaffold. SAR studies led to the identification of 6,7-dihydro-5H- benzo[5,6][1,4] diazepino[7,1-a]indoles (19 and 20) bearing a basic pendent group with high biochemical and cellular potencies. These compounds displayed a very small shift in cellular potency when the replicon assay was performed in the presence of human serum albumin.

引用

页码：6950 / 6953

页数：4

共 24 条

[1]

AFDHAL N, 2005, 40 EASL PAR FRAND AP

[2]

Beaulieu P. L., 2003, Int. Patent Appl., Patent No. [WO 03010140, 03010140]

[3] Non-nucleoside benzimidazole-based allosteric inhibitors of the hepatitis C virus NS5B polymerase: Inhibition of subgenomic hepatitis C virus RNA replicons in Huh-7 cells [J].

Beaulieu, PL ;

Bousquet, Y ;

Gauthier, J ;

Gillard, J ;

Marquis, M ;

McKercher, G ;

Pellerin, C ;

Valois, S ;

Kukolj, G .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (27) :6884-6892

[4] Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase:: discovery and preliminary SAR of benzimidazole derivatives [J].

Beaulieu, PL ;

Bös, M ;

Bousquet, Y ;

Fazal, G ;

Gauthier, J ;

Gillard, J ;

Goulet, S ;

LaPlante, S ;

Poupart, MA ;

Lefebvre, S ;

McKercher, G ;

Pellerin, C ;

Austel, V ;

Kukolj, G .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (01) :119-124

[5]

CHANDRA C, 2006, DDW 2006 LOS ANG MAY

[6]

CONTE I, 2006, Patent No. 2006046030

[7]

COULOMBE R, 2004, Patent No. 2004099241

[8] Challenges and successes in developing new therapies for hepatitis C [J].

De Francesco, R ;

Migliaccio, G .

NATURE, 2005, 436 (7053) :953-960

[9] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. [J].

Fried, MW ;

Shiffman, ML ;

Reddy, KR ;

Smith, C ;

Marinos, G ;

Goncales, FL ;

Haussinger, D ;

Diago, M ;

Carosi, G ;

Dhumeaux, D ;

Craxi, A ;

Lin, A ;

Hoffman, J ;

Yu, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :975-982

[10] Control of hepatitis C: A medicinal chemistry perspective [J].

Gordon, CP ;

Keller, PA .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) :1-20

← 1 2 3 →